Risk of Second Cancer in Erdheim-Chester Disease

0 avis

Risk of Second Cancer in Erdheim-Chester Disease

Archive ouverte

Edité par CCSD ; American Medical Association -

International audience. This cohort study analyzes the risk of second cancers in a cohort of 515 patients with Erdheim-Chester disease followed up at 2 histiocytosis centers in France and Italy.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Archive ouverte | Durham, Benjamin | CCSD

International audience. Langerhans cell histiocytosis (LCH) and the non-LCH neoplasm Erdheim-Chester disease (ECD) are heterogeneous neoplastic disorders marked by infiltration of pathologic macrophage-, dendritic c...

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Archive ouverte | Papo, Matthias | CCSD

International audience. Key Points Some 10.1% of adults with non–Langerhans cell histiocytosis have a concomitant myeloid neoplasm with each often harboring distinct mutations. The presence of distinct kinase mutati...

Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells

Archive ouverte | Papo, Matthias | CCSD

International audience

Chargement des enrichissements...